SP-MHCI-0671-3

Human Glutamine synthetase 361-373, LNETGDEPFQYKN

US$507.00

In stock

Description

About Human Glutamine synthetase 361-373, LNETGDEPFQYKN

The Human Glutamine synthetase Peptide (IEDB: 120079) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Glutamine synthetase Peptide, H-LNETGDEPFQYKN-OH (Uniprot: P15104 aa: 361-373) from JPT is produced under strict quality control and quality management.

Human Glutamine synthetase 361-373, LNETGDEPFQYKN - Specifications

  • Peptide sequence: H-LNETGDEPFQYKN-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Arthritis, Multiple sclerosis, Autoimmune disease, non-Hodgkin lymphoma
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Glutamine synthetase 361-373, LNETGDEPFQYKN

References:
Read References with JPT’s Antigen Peptides
Human Glutamine synthetase 361-373, LNETGDEPFQYKN has been described in:
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients., Mol Cell Proteomics, 2009 (PMID: 19531498)
The first step of peptide selection in antigen presentation by MHC class I molecules., Proc Natl Acad Sci U S A, 2015 (PMID: 25605945)
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides., Prostate, 1998 (PMID: 9650914)

Documentation

Documentation for Human Glutamine synthetase 361-373, LNETGDEPFQYKN

Properties

Properties of Human Glutamine synthetase 361-373, LNETGDEPFQYKN

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Arthritis, Autoimmune disease, Multiple sclerosis, non-Hodgkin lymphoma
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Glutamine synthetase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Glutamine synthetase 361-373, LNETGDEPFQYKN

Information Values
Sequence: H-LNETGDEPFQYKN-OH
Specifications: 13mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote